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Abstract
Background: It is controversial whether selective endoscopic sphincterotomy or routine laparoscopic bile duct exploration is
the optimal treatment for choledocholithiasis. Magnetic resonance cholangio-pancreatography (MRCP) is a safe and
accurate imaging modality; this study evaluated its use in a clinical algorithm for the management of suspected
choledocholithiasis. Patients and methods: Consecutive patients presenting with suspected common bile duct (CBD) stones
were managed according to an algorithm involving the selective use of MRCP to identify patients who required endoscopic
sphincterotomy and bile duct clearance. Following radiological demonstration of a clear CBD, all patients were considered
for cholecystectomy. Results: From 157 consecutive patients, 68 proceeded straight to endoscopic sphincterotomy, which
was therapeutic in 59. Of 89 who underwent MRCP, choledocholithiasis was demonstrated in 29; subsequent endoscopic
sphincterotomy was therapeutic in 22. MRCP demonstrated a clear CBD in the remaining 60 patients. Seventy-four
patients subsequently underwent cholecystectomy, with a conversion rate of 9% and a median postoperative stay of 1 day.
There were no instances of post-sphincterotomy pancreatitis or haemorrhage requiring transfusion. Conclusion: An
algorithm involving selective MRCP with endoscopic sphincterotomy is a safe, effective means of managing suspected
choledocholithiasis, particularly where the expertise, equipment or theatre time for laparoscopic bile duct exploration is not
routinely available.
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Introduction
Common bile duct (CBD) stones are present in some
12% of patients with symptomatic gallstone disease.
In the majority of cases, choledocholithiasis is pre-
dictable on the basis of clinical, biochemical and
radiological examination; however, a small proportion
of patients have unsuspected CBD stones. There is
considerable debate over whether intraoperative ima-
ging of the CBD should be performed in all patients
or only in those with suspected CBD stones. There is
also controversy over whether CBD stones are opti-
mally treated by preoperative endoscopic sphincter-
otomy or by intraoperative laparoscopic exploration of
the CBD.
Magnetic resonance cholangio-pancreatography
(MRCP) is a safe, non-invasive means of imaging
the biliary tree, whose accuracy for detecting CBD
stones approaches 100% [1]. Although not yet widely
available, MRCP has been assessed prospectively as a
means of selecting patients with CBD stones for
preoperative endoscopic sphincterotomy [2,3]; it is
suggested that this approach might both avoid the
need for intraoperative CBD imaging and reduce the
unnecessary endoscopic sphincterotomy rate.
Frimley Park Hospital is a District General Hospital
serving a population of 400 000; gallstone disease is
managed by two specialist upper GI surgeons who
perform endoscopic retrograde cholangio-pancreato-
graphy (ERCP). All patients with suspected CBD
stones are managed according to a clinical algorithm
involving the selective use of MRCP to determine
whether patients require preoperative clearance of the
CBD by endoscopic sphincterotomy. Once the CBD
is clear of stones, cholecystectomy is performed
according to medical fitness and patient choice.
This retrospective study reports the application of
selective MRCP, endoscopic sphincterotomy and
cholecystectomy in all patients admitted with sus-
pected CBD stones during the year 2004.
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Patients and methods
All patients presenting to Frimley Park Hospital with
gallstone-related disease in the year 2004 were man-
aged according to a clinical algorithm (Figure 1).
Previous and current clinical, biochemical and radi-
ological indices were used to assess the need for
preoperative evaluation of the CBD. Where there was
a low suspicion of previous or current CBD stones,
patients proceeded directly to cholecystectomy. Those
with a high suspicion of CBD stones (CBD stones on
ultrasound, cholangitis, pancreatitis, current elevated
liver function tests  LFTs) proceeded straight to
ERCP and sphincterotomy. Equivocal cases under-
went MRI cholangio-pancreatography, and the results
of this were used to select patients for subsequent
ERCP and sphincterotomy. Once the CBD was
confirmed clear of stones, all patients were considered
for cholecystectomy, and an informed decision was
taken according to age, coexisting medical conditions
and patient preference.
Hospital discharge data, a computerized radiology
database, endoscopy procedure records, the pathol-
ogy database and operating logbooks were inspected
to find all patients who underwent ERCP, MRCP or
cholecystectomy during the year 2004. The details of
all patients investigated or treated for CBD stones
were entered into a spreadsheet (Excel, Microsoft).
Notes for all these patients were scrutinized, and
relevant data were added to the Excel spreadsheet.
MRCP was performed using 1.5 Tesla Siemens
Symphony scanner.
ERCP was carried out by one of two specialist
upper GI surgeons. Sedation (midazolam), analgesia
(fentanyl) and anti-spasmodics (hyoscine butylbro-
mide) were routinely given, and monitoring was in
accordance with BSG guidelines. A side-viewing
scope was used to visualize the ampulla, and retro-
grade cholangiography was performed, using a pre-
cut sphincterotomy if required. Gallstones were re-
moved using sphincterotomy, balloon trawling and
Dormia basket. In patients at risk of retained or
recurrent CBD stones, a plastic stent was deployed to
facilitate biliary drainage; this was removed or re-
placed as required after 6 weeks.
Laparoscopic cholecystectomy was normally per-
formed by one of two specialist upper GI surgeons or
their supervised trainees. A Veress needle was used to
establish a 12 mmHg capnoperitoneum, and a stan-
dard four-port technique was used to dissect out
Calot’s triangle using hook diathermy and Petelin’s
grasper as required. After clipping and dividing the
cystic duct and artery, the gallbladder was excised
from the liver bed using hook diathermy and removed
via the umbilical port, in a retrieval bag if necessary.
Intra-abdominal drains were not routinely placed, and
patients were normally discharged home when eating,
mobilizing and sufficiently analgesed.
Quantitative data are expressed as mean, median or
percentages. Ethics committee approval was not
required for this study, nor was any statistical manip-
ulation necessary.
Results
A total of 157 patients with clinical, biochemical or
radiological suspicion of choledocholithiasis were
admitted to Frimley Park Hospital in the year 2004
(Figure 2). Median age was 65 years (range 2099)
and 109 (69%) were female. More than 350 further
patients presented with cholelithiasis during the









High suspicion of CBD
Figure 1. Clinical algorithm for the management of patients with suspected common bile duct (CBD) stones.
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12 month period; these were considered at low risk of
CBD stones, and are not considered further.
Sixty-eight patients were considered at high risk of
CBD stones, and proceeded straight to ERCP and
sphincterotomy; cannulation of the CBD was
achieved in 67 of these (99%), and gallstones were
demonstrated in 59 (88%). The CBD was conclu-
sively cleared in 36 (61%) patients with CBD stones,
while a plastic stent was placed in the remaining 23
patients in whom recurrent or retained stones could
not be excluded. The remaining patient, following
failed ERCP, underwent laparoscopic CBD explora-
tion, with successful removal of stones from the CBD.
The remaining 89 patients were considered equi-
vocal for CBD stones, and underwent MRCP to
further investigate the status of the bile duct. In 60
patients (67%), the CBD was reported as clear, while
29 (33%) were shown to have gallstones in the CBD.
In all, 28 of these 29 underwent ERCP; cannulation
of the CBD was achieved in 26 of them, and
gallstones were demonstrated in 22. The CBD was
conclusively cleared in 18 patients, while a plastic
stent was placed in the remaining 4 patients in whom
recurrent or retained stones could not be excluded.
Two patients in whom ERCP failed for anatomical
reasons proceeded to surgery; one patient with a
previous Polya gastrectomy underwent open chole-
cystectomy and transduodenal exploration of the
CBD, with removal of several stones, while a patient
with duodenal stenosis proceeded to laparoscopic
CBD exploration, with successful removal of stones
from the CBD. The remaining patient in whom
MRCP demonstrated CBD stones opted for laparo-
scopic CBD exploration and stone removal, which
was successful.
Overall, 96 patients underwent ERCP, which was
successful in 93 (97%). CBD stones were demon-
strated in 81 of 93 (87%) successful ERCPs, and in all
cases the CBD was cleared of stones (n54; 67%) or
stented (n27; 33%).
Of 27 patients who underwent stent insertion, 19
were considered unfit for cholecystectomy due to age
and medical co-morbidities. In the remaining eight
patients, stents were placed due to Mirizzi syndrome
(n2), ascending cholangitis (n2) or uncertainty
over CBD clearance.
In 60 of 89 patients equivocal for CBD stones,
MRCP demonstrated a clear CBD; this obviated the
need for ERCP or intraoperative cholangiography
(IOC) in these 60 patients. Selective use of MRCP
could be considered to have limited the number of
patients undergoing ERCP from 157 to 96, and thus
reduced the negative ERCP rate from 48% to 16%.
There were no incidences of post-ERCP pancrea-
titis or haemorrhage requiring transfusion; one patient
(aged 99) with overwhelming sepsis due to ascending
cholangitis died 2 days following successful ERCP
and sphincterotomy.
Four patients had undergone cholecystectomy in
the month prior to presenting with suspected CBD
stones. One patient had refused MRCP on the
grounds of claustrophobia, despite moderate suspi-
cion of CBD stones; IOC demonstrated several CBD
stones, which were removed at endoscopic sphincter-
otomy 3 days after cholecystectomy. One patient
underwent endoscopic sphincterotomy followed by
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153 – no stones in
CBD
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in CBD
Figure 2. Results of algorithm for the management of 157 patients with suspected common bile duct (CBD) stones. This figure does not
include over 350 further patients with cholelithiasis in whom there was a low suspicion of CBD stones.
MRCP in the management of CBD stones 127
with obstructive jaundice 3 weeks later; ERCP
demonstrated a further CBD calculus, which was
removed. The remaining two patients, despite no
preoperative clinical, biochemical or radiological in-
dications of choledocholithiasis, developed obstruc-
tive jaundice at 3 and 4 weeks after cholecystectomy.
In both cases, ERCP was used to demonstrate and
treat unsuspected CBD stones. A total of over 400
cholecystectomies were performed at our unit during
the year 2004, giving an incidence of unsuspected
CBD stones of B1%.
Eleven patients had undergone cholecystectomy at
least 1 year before presenting with suspected CBD
stones (range 15 months to 30 years, median 4 years).
In six of these patients, MRCP demonstrated no
stones in the CBD, although one was found to have an
ampullary tumour. In the remaining five patients,
ERCP demonstrated recurrent or retained CBD
stones, which were successfully treated endoscopi-
cally.
Following confirmation of a clear CBD, patients
were considered for cholecystectomy, depending on
age, co-morbidity and choice. In all, 74 of 142
patients underwent laparoscopic cholecystectomy, 7
(9%) of which were converted to open operation. Of
74 patients aged 70 years and under, 63 (85%)
underwent laparoscopic cholecystectomy, with 6 re-
quiring conversion to open procedure (10%). There
were no deaths or bile duct injuries following chole-
cystectomy. Mean postoperative hospital stay was 2.4
days (median 1 day); mean postoperative stay follow-
ing laparoscopic cholecystectomy was 1.7 days, while
that following open cholecystectomy was 7.4 days.
Discussion
This paper reports on the clinical application of a
simple algorithm for the management of suspected
CBD stones, and demonstrates that selective MRCP,
with subsequent ERCP and laparoscopic cholecys-
tectomy where appropriate, is a safe, successful and
effective means of treating this common clinical
problem.
The incidence of CBD stones among patients
undergoing cholecystectomy is reported as 12%. In
some cases, their presence is suspected on the basis of
clinical history and examination; in others, abnormal
liver function tests or a dilated CBD at ultrasound are
the only clue, while a small percentage of patients
have ‘silent’ or unsuspected CBD stones. Both before
and since the advent of minimally invasive surgery,
there has been controversy over whether the biliary
tree should routinely be imaged during cholecystect-
omy. Some surgeons perform IOC in all patients,
while others do so only in patients where there is
clinical, biochemical or radiological evidence of CBD
stones. Furthermore, there is considerable confusion
over the optimum means of treating CBD stones; in
some centres the preferred method is ERCP with
sphincterotomy, while other centres undertake laparo-
scopic exploration of the CBD during cholecystect-
omy. Finally, there is uncertainty over whether the
gallbladder should be removed following endoscopic
clearance of the CBD, or should sphincterotomy be
considered the definitive treatment.
Routine IOC is advocated by some surgeons for
several reasons. Firstly there is potential for unsus-
pected CBD stones in every patient presenting for
cholecystectomy, and so routine imaging is the only
way of establishing that the CBD is clear. However, a
more selective approach is supported by evidence that
only 1% of patients with normal liver function tests
and normal calibre bile duct at ultrasound harbour
stones in the CBD [4], and that over three-quarters of
CBD stones pass spontaneously [5,6]. Cholangiogra-
phy has a failure rate, and can give false negatives and
false positives, leading to missed CBD stones and to
unnecessary exploration of the CBD, respectively [7].
It also adds a certain amount of time to the operation,
partly in surgical dissection and cannulation, and
partly related to radiography [8]. Secondly, it is
claimed that cholangiography accurately delineates
the biliary anatomy, thus reducing the risk of bile duct
injury. This controversy is discussed in a recent review
[9]; although the largest population study suggests
that routine IOC does reduce the risk of bile duct
damage by about a third [10], such studies are open to
bias, and there are no randomized controlled studies
demonstrating a link. There is stronger evidence that
routine IOC enables earlier detection of injury to the
CBD, which may lead to improved outcome following
appropriate early repair [11]. However, reports from
other centres where IOC is not routinely performed
have shown that the most effective means of prevent-
ing CBD injury is meticulous dissection with correct
interpretation of the anatomy [12].
The clinical application of routine laparoscopic
CBD exploration has recently been described [13],
along with an exhaustive review of the literature
comparing this approach with endoscopic sphincter-
otomy [14]. The authors report 224 consecutive
patients with CBD stones who were deemed fit for
laparoscopic cholecystectomy; the overall CBD clear-
ance rate was 96%, with higher clearance rates
following the addition of lithotripsy to the armamen-
tarium. However, the rate of conversion to open
operation was 13%, with over half of these attributed
to the CBD exploration, and the postoperative
complication rate was 19%, which might be consid-
ered high in a group of patients of mean age 56 years.
Also, the mean postoperative hospital stay in 158
patients undergoing transductal exploration was 4.8
days, considerably longer than in most centres per-
forming elective or urgent laparoscopic cholecystect-
omy. Routine IOC and laparoscopic CBD exploration
add an unpredictable amount of time to operative
duration [8], which is important in hospitals where
theatre time is at a premium. All of these factors make
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laparoscopic CBD exploration unattractive for day-
case surgery. In addition to these immediate draw-
backs of laparoscopic CBD exploration, there are as
yet no follow-up data to conclusively demonstrate the
absence of long-term sequelae. In particular, it is
uncertain whether stenosis of the CBD following
dissection and suturing of a longitudinal choledochot-
omy might lead to further stone formation or tumor-
igenesis. Finally, it should be noted that 149 patients
with CBD stones were excluded from this study as
they were considered unfit for laparoscopic cholecys-
tectomy; these patients underwent ERCP and duct
clearance as definitive treatment.
ERCP with sphincterotomy is considered inferior
by proponents of laparoscopic CBD exploration for
several reasons. Firstly, ERCP is thought to have a
lower rate of stone clearance than laparoscopic CBD
exploration; however, analysis of the randomized trials
comparing the two techniques showed a similar over-
all duct clearance rate, with some centres reporting a
100% duct clearance at ERCP [14]. Each technique
has a learning curve, and it is likely that despite the
occasional difficulty or failure, experienced practi-
tioners of either method will have a success rate
approaching 100%. Secondly, ERCP is associated
with several complications, most notably pancreatitis,
which is reported to occur in up to 7% of cases and
has a definite mortality [15]. Pancreatitis has occa-
sionally been reported following laparoscopic CBD
exploration, but only in cases where instruments have
transgressed the sphincter of Oddi. However, the
incidence of pancreatitis following ERCP and sphinc-
terotomy is related to technical factors rather than to
co-existent medical factors. Several large studies have
shown that the risk is higher in young female patients,
and increased by repeated cannulation of the pan-
creatic duct, performance of a pre-cut sphincterot-
omy, and failure to clear the CBD of stones [16,17].
Finally, ERCP and sphincterotomy is postulated by
some to encourage permanent duodenalbiliary re-
flux, leading to formation of further bile duct stones
and the possible development of biliary malignancy.
However, the few studies that report a significant
incidence of recurrent gallstone formation after ERCP
and sphincterotomy relate either to the formation of
further pigment-type stones in patients whose original
gallstones were pigment stones, or to patients with the
gallbladder still in situ following endoscopic sphinc-
terotomy [18]. Also, although there is a reported
incidence of malignancy following biliaryenteric
anastomoses [19], there is no clinical evidence that
endoscopic sphincterotomy is associated with the
increased development of biliary cancer; any such
increase would of course be difficult to differentiate
from the known carcinogenic effects of long-term
cholelithiasis. Thus, although ERCP and sphincter-
otomy is considered by some to be risky, critical
analysis of the literature spanning over 25 years
suggests that when performed by experienced practi-
tioners, it leads to a high rate of CBD clearance with
minimal short- and long-term complications. In the
series described here, comprising over 100 ERCPs, no
significant complications occurred, and the only death
was attributed to multi-organ failure caused by
ascending cholangitis.
MRCP is a non-invasive imaging method that is
highly sensitive and specific for the detection of CBD
stones. It is quick, safe, well tolerated by most people,
and has few contraindications and no known morbid-
ity or mortality. Most recent studies comparing
MRCP with IOC or ERCP findings have confirmed
that MRCP has an accuracy of 95%; in particular
the negative predictive value approaches 100%
[1,20,21]. Several reports comparing MRCP findings
with those at subsequent ERCP have concluded that
reliance upon MRCP might have reduced the require-
ment for ERCP and sphincterotomy by up to 75%
[1,2]. For these reasons, MRCP has been incorpo-
rated into the pathway for the investigation of
suspected CBD stones at our institution. Apart from
occasional claustrophobic patients, it has proved
highly acceptable, and has been pivotal in reducing
the rate of ‘negative’ ERCPs to a minimum. No
patient whose MRCP demonstrated a clear CBD
returned with symptomatic CBD stones throughout
the duration of this study, confirming the high
negative predictive value for MRCP.
There are conflicting opinions as to whether the
gallbladder should be removed following successful
CBD clearance. Further incidences of gallstone-
related pathology have been reported in only 516%
of patients whose gallbladder is left in situ following
ERCP and sphincterotomy, leading some to conclude
that cholecystectomy is not required [22,23]. This
contrasts with the findings of a randomized controlled
trial involving 120 patients who, following CBD
clearance, were randomly allocated to a wait-and-see
approach or to cholecystectomy [24]. Over a 2-year
period, 47% of patients allocated to the wait-and-see
group presented with further gallstone-related symp-
toms and 37% required cholecystectomy, with a
conversion rate of 55%. Our policy is to select patients
for cholecystectomy according to age, co-morbidities
and patient choice; those for whom sphincterotomy is
considered definitive treatment are quoted a 1 in 7
risk for further gallstone-related symptoms. Where
cholecystectomy is to be performed, our and others’
data suggest that it should be done as soon as possible,
to avoid the risk of patients presenting with further
gallstone-related symptoms whilst awaiting elective
cholecystectomy [25]. In the hands of specialist
surgeons, such a policy is not associated with an
increased risk of conversion or other complications.
The conversion rate of 10% reported in this series
compares well with published reports, particularly
considering that patients with CBD stones have an
increased degree of fibrosis, and thus have a higher
risk of conversion to open surgery.
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Conclusion
We have devised and implemented an algorithm that
uses liver function tests and transabdominal ultra-
sound to divide patients with suspected CBD stones
into three groups. Those with normal LFTs and CBD
diameter require no further imaging; those with a high
suspicion of current bile duct stones progress directly
to ERCP; the remainder, where the CBD status is
uncertain, undergo further investigation using MRCP.
Patients in whom MRCP demonstrates CBD stones
undergo ERCP with sphincterotomy, while those with
a clear CBD require no further investigation. All
patients are then considered for laparoscopic chole-
cystectomy, with the decision to operate based upon
age, medical fitness and patient choice. The results of
this policy, as described in this paper, demonstrate
that it is a robust, safe, effective means of investigating
and treating CBD stones, and we recommend it for
use in other hospitals.
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